SFX by Ex Libris Inc.

Title:	Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases
Source:	European Journal of Human Genetics [1018-4813] Burwinkel, Barbara yr:2003

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	DiMauro, S. "A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy." Biochemical and biophysical research communications 249.3 (1998): 648-51.
description	2.	Angelini, C. "Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient." Muscle & nerve 21.6 (1998): 769-775.
description	3.	Wuyts, W. "Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene." American journal of medical genetics. Part A 133A.1 (2005): 82-84.
description	4.	Bak, H. "Adult-onset exercise intolerance due to phosphorylase b kinase deficiency." Journal of clinical neuroscience 8.3 (2001): 286-7.
description	5.	WILKINSON, D. "CLINICAL AND BIOCHEMICAL FEATURES OF 10 ADULT PATIENTS WITH MUSCLE PHOSPHORYLASE-KINASE DEFICIENCY." Neurology 44.3 (1994): 461-466.
description	6.	Beauchamp, N. "Glycogen storage disease type IX: High variability in clinical phenotype." Molecular genetics and metabolism 92.1-2 (2007): 88-99.
description	7.	DiMauro, S. "Glycogen storage diseases of muscle." Current opinion in neurology 11.5 (1998): 477-84.
description	8.	de Lonlay, P. "A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure." Nature genetics 29.1 (2001): 57-60.
description	9.	Burwinkel, B. "Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency." American journal of human genetics 76.6 (2005): 1034-49.
description	10.	Pons, R. "Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis." Neurology 62.7: 1058-1065.
description	11.	Schippers, H. "Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX)." Journal of inherited metabolic disease 26.1 (2003): 43-47.
description	12.	Ozen, H. "Glycogen storage diseases: new perspectives." Shi Jie Wei Chang Bing Xue Za Zhi （ Ying Wen Ban ） 13.18 (2007): 2541-53.
description	13.	HYLAND, K. "AROMATIC L-AMINO-ACID DECARBOXYLASE DEFICIENCY - CLINICAL-FEATURES, DIAGNOSIS, AND TREATMENT OF A NEW INBORN ERROR OF NEUROTRANSMITTER AMINE SYNTHESIS." Neurology 42.10 (1992): 1980-1988.
description	14.	DiDonato, S. "Pathways to motor incoordination: the inherited ataxias." Nature reviews. Neuroscience 5.8 (2004): 641-55.
description	15.	Quinlivan, R. "Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V)." The Cochrane database of systematic reviews 2 (2004).
description	16.	Dionisi-Vici, C. "Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy." The Journal of pediatrics 136.4 (2000): 560-2.
description	17.	Shin, Yoon S S. "Glycogen storage disease: clinical, biochemical, and molecular heterogeneity." Seminars in pediatric neurology 13.2 (2006): 115-20.
description	18.	Kollberg, G. "Brief report: Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0." New England Journal of Medicine, The 2007. 1507-1514.
description	19.	Storch, E. "Psychosocial functioning in youth with glycogen storage disease type 1." Journal of Pediatric Psychology 33.7 (2008): 728-738.
description	20.	Davey, Peter G G. "The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection." The Lancet infectious diseases 7.4 (2007): 282-8.